Product NDC: | 25021-203 |
Proprietary Name: | Epirubicin Hydrochloride |
Non Proprietary Name: | epirubicin hydrochloride |
Active Ingredient(s): | 2 mg/mL & nbsp; epirubicin hydrochloride |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 25021-203 |
Labeler Name: | Sagent Pharmaceutical |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065445 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090908 |
Package NDC: | 25021-203-25 |
Package Description: | 1 VIAL in 1 CARTON (25021-203-25) > 25 mL in 1 VIAL |
NDC Code | 25021-203-25 |
Proprietary Name | Epirubicin Hydrochloride |
Package Description | 1 VIAL in 1 CARTON (25021-203-25) > 25 mL in 1 VIAL |
Product NDC | 25021-203 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | epirubicin hydrochloride |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20090908 |
Marketing Category Name | ANDA |
Labeler Name | Sagent Pharmaceutical |
Substance Name | EPIRUBICIN HYDROCHLORIDE |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] |